Intellectual Property & Science is now known as Clarivate Analytics

Intellectual Property & Science is now known as Clarivate Analytics

...and is no longer part of Thomson Reuters. You can still explore their products on this page.

Drug Development

Get your drug ready for market faster. Enrich your drug R&D with expert insight and multi-disciplined data.

Guide your promising compound through key development milestones more effectively. Access chemical, biological, and pharmacological data and analytics. Curated by scientists, who understand the moving parts of drug development. Covering all angles, from metabolics and structure relationships to patents and clinical trials. Our offerings include: Scientific R&D intelligence, Pharmaceutical market intelligence, IP intelligence, and Regulatory intelligence. 
Contact Sales

Drug Development Products:


Thomson Reuters Integrity℠ provides researchers with reliable, detailed information, from the perspective of a scientist, across multiple disciplines to support successful drug research and development.

Cortellis Opportunity Monitor

Cortellis Opportunity Monitor automatically watches for industry developments that affect the status of drug licensing candidates you’ve previously considered.

Pipeline Compare

Combines pipeline data from multiple commercial databases into one system where customers can search across the consolidated data. The key feature of Pipeline Compare is the sophisticated mapping process that Thomson Reuters has developed.

MetaCore and Key Pathway Advisor

MetaCore™ is an integrated software suite for functional analysis of microarray, metabolic, SAGE, proteomics, siRNA, microRNA, and screening data.


BioWorld™ Today delivers actionable intelligence on the biotech science that drives the business, which funds the means to heal disease.

The Incidence & Prevalence Database

The Incidence and Prevalence Database, the most efficient way to look at the world’s epidemiology data. Covering over 4,500 diseases, procedures, symptoms and other health issues for incidence, prevalence, morbidity, mortality, comorbidity, treated or diagnosed rates and more.

Drug News

Selects the latest, most important drug discovery and development news every day, places it in context, and presents it online and as email alerts in a clear, concise format that makes it easy to discover the important facts at a glance.

Medical Device Daily

Medical Device Daily™ is the news source of record for the high-tech medical technology industry and is relied on by thousands of industry insiders every business morning.

IP Data Feeds - Markush Structures

When combined with a user-friendly search and analysis tool, the data set enables you to quickly determine which patents are relevant to your research. Gives you a complete picture of patented chemistry, ideal for patentability searching.